TY - THES A1 - Vollmuth, Christina T1 - Untersuchungen zum Überleben bei zwei zeitlich definierten Kohorten von Patienten mit multiplem Myelom T1 - Comparison of overall survival rates in two cohorts of patients with multiple myeloma: 1990-1996 and 1997-2002 N2 - Das multiple Myelom, eine maligne Plasmazell-Dyskrasie, ist bis heute unheilbar. Eine Verbesserung des medianen Überlebens von weniger als 2 auf über 3 Jahre wurde erstmals 1996 durch eine prospektiv randomisierte Studie von Attal et al. gezeigt. Die retrospektive Analyse zweier zeitlich definierter Kohorten, Kohorte 1 (1990-1996) und Kohorte 2 (1997-2002), zur Überprüfung des Therapieerfolges am Universitätsklinikum Würzburg zeigt unter Berücksichtigung aller Patienten keinen Überlebensvorteil für Patienten der 2.Kohorte. Signifikant profitiert haben allerdings Patienten bis max. 65 Jahre der Kohorte 2, die durch die HD-Therapie ein 5-JÜL von 50% (Kohorte 2) vs.32% (Kohorte 1) erreichten, wohingegen sich für ältere Patienten keine signifikant messbaren Überlebensvorteile ergaben. N2 - The median overall survival of patients with multiple myeloma did not exceed more than 2 years for a long time. 1996 Attal et al. published a randomized prospective trial that showed a median survival of more than 3 years in patients who went through a high-dosed chemotherapy and autologous stem cell transplantation. This retrospective analysis in two cohorts compares the overall survival rates of newly diagnosed myeloma patients between 1990-1996 (cohort 1) and 1997-2002 (cohort 2). A significant benefit in 5 year survival rates could be shown for patients younger or max. 65 years(50% C.2 vs. 32% C.1). The overall survival of patients older than 65 years, who did not receive a high-dose therapy, did not improve. The high-dose therapy with autologous stem cell retransfusion seems to be the most important factor to improve the overall survival of patients. KW - Plasmozytom KW - Überleben KW - autologe Stammzelltransplantation KW - retrospektiv KW - Therapie KW - multiple myeloma KW - overall survival KW - stem cell transplantation KW - retrospective KW - treatment Y1 - 2010 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-53769 ER - TY - JOUR A1 - Wieching, Anna A1 - Benser, Jasmin A1 - Kohlhauser-Vollmuth, Christina A1 - Weisbrich, Bendikt A1 - Streng, Andrea A1 - Liese, Johannes G. T1 - Clinical characteristics of pediatric hospitalizations associated with 2009 pandemic influenza a (H1N1) in Northern Bavaria, Germany N2 - Background: The 2009 pandemic influenza A (H1N1) (PIA) virus infected large parts of the pediatric population with a wide clinical spectrum and an initially unknown complication rate. The aims of our study were to define clinical characteristics and outcome of pandemic influenza A (H1N1) 2009-associated hospitalizations (PIAH) in children <18 years of age. All hospitalized cases of children <18 years of age with laboratory-confirmed pandemic influenza A (H1N1) 2009 in the region of Wuerzburg (Northern Bavaria, Germany) between July 2009 and March 2010 were identified. For these children a medical chart review was performed to determine their clinical characteristics and complications. Results: Between July 2009 and March 2010, 94 PIAH (62% males) occurred in children <18 years of age, with a median age of 7 years (IQR: 3–12 years). Underlying diseases and predisposing factors were documented in 40 (43%) children; obesity (n = 12, 30%), asthma (n = 10, 25%) and neurologic disorders (n = 8, 20%) were most frequently reported. Sixteen (17%) children received oxygen supplementation; three (3%) children required mechanical ventilation. Six (6%) children were admitted to an intensive care unit, four of them with underlying chronic diseases. Conclusions: Most PIAH demonstrated a benign course of disease. However, six children (6%) needed treatment at an intensive care unit for severe complications. KW - Medizin KW - Influenza KW - Pediatric KW - Infectious disease KW - Hospitalization Y1 - 2012 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-75657 ER -